This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Maxwell Biotech Group Ltd., Garini Technologies Corporation, Skolkovo Institute of Science and Technology. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
1 out of 3 
1 out of 11 
Years Active: 2018-2026
Title: Ekaterina Alekseevna Ivanova: Innovator in Oncology and Pharmaceuticals
Introduction
Ekaterina Alekseevna Ivanova is a prominent inventor based in Moscow, Russia. She has made significant contributions to the fields of medicine and pharmaceuticals, particularly in oncology. With a total of 4 patents to her name, her work focuses on developing innovative treatments for bone lesions caused by malignant neoplasms.
Latest Patents
Ivanova's latest patents include a stable dosage form of etidronate-cytarabine conjugate, which ensures the hydrolytic and physical stability of the preparation. This novel dosage form is a lyophilizate that comprises an etidronate-cytarabine conjugate or a pharmaceutically acceptable salt thereof, along with a stabilizer. The stabilizer is a divalent metal salt, and the molar ratio of stabilizer to conjugate ranges from 1:1 to 20:1. This formulation guarantees the stability of the conjugate during long-term storage and clinical use.
Another significant patent involves a pharmaceutical preparation for treating bone lesions caused by malignant neoplasms. This medicinal drug is presented as a lyophilisate for solution for parenteral administration. It includes a pharmaceutically acceptable salt of the divalent metal and a specific compound with a molar ratio of components ranging from 1:1 to 20:1. The treatment method allows for intravenous drop infusions, significantly reducing the metabolic activity of bone lesions caused by malignant tumors.
Career Highlights
Throughout her career, Ivanova has worked with notable companies such as Maxwell Biotech Group Ltd. and Garini Technologies Corporation. Her experience in these organizations has contributed to her expertise in developing innovative pharmaceutical solutions.
Collaborations
Ivanova has collaborated with esteemed colleagues, including Alexander Karpeisky and Shawn Patrick Zinnen. These partnerships have further enhanced her research and development efforts in the pharmaceutical field.
Conclusion
Ekaterina Alekseevna Ivanova is a trailblazer in the field of oncology and pharmaceuticals, with a focus on innovative treatments for bone lesions. Her contributions through her patents and collaborations highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile